Cetirizine Hydrochloride + Phenylephrine Hydrochloride + Guaiphenesin + Paracetamol + Dextromethorphan HydrobromideThird Party Manufacturing in India

Cetirizine Hydrochloride + Phenylephrine Hydrochloride + Guaiphenesin + Paracetamol + Dextromethorphan Hydrobromide is a comprehensive five-ingredient fixed-dose combination that addresses the full spectrum of cold and flu symptoms. Each component works through a distinct pharmacological mechanism to provide simultaneous relief from nasal congestion, allergy symptoms, cough, fever, pain, and chest congestion.

Cetirizine is a selective peripheral histamine H₁ receptor antagonist. By blocking histamine binding, it reduces sneezing, rhinorrhoea, nasal itching, and ocular allergy symptoms. As a second-generation antihistamine, it has minimal sedative effects due to its limited penetration of the blood-brain barrier.

Phenylephrine selectively activates alpha-1 adrenergic receptors on vascular smooth muscle in the nasal mucosa. The resulting vasoconstriction reduces tissue oedema and congestion, restoring patency of nasal airways and sinus drainage.

Guaiphenesin acts as an expectorant by increasing the volume and reducing the viscosity of respiratory tract secretions. It stimulates bronchial mucosal glands to produce thinner, less sticky mucus, which facilitates productive coughing and clears phlegm from the airways. This helps patients expel accumulated mucus more effectively.

Paracetamol provides central analgesic and antipyretic effects by inhibiting COX enzymes in the brain, reducing prostaglandin synthesis. This lowers fever and relieves headache, body aches, and sore throat pain associated with upper respiratory infections.

Dextromethorphan is a centrally acting cough suppressant that elevates the cough threshold. It binds to NMDA receptors and sigma-1 receptors in the cough centre of the medulla oblongata, reducing the frequency and intensity of non-productive cough without affecting ciliary activity.

Therapeutic Uses

This five-component combination is indicated for the comprehensive symptomatic relief of the common cold, flu, and upper respiratory tract infections. It is particularly valuable when multiple symptoms present simultaneously:

• Nasal congestion and sinusitis: Phenylephrine relieves stuffy nose and sinus pressure through vasoconstriction of nasal blood vessels, restoring normal breathing and sinus drainage.
• Cough (dry/irritating): Dextromethorphan suppresses non-productive cough by acting on the central cough centre, providing relief from persistent, irritating cough that disrupts sleep and daily activities.
• Chest congestion and phlegm: Guaiphenesin thins and loosens mucus in the airways, making coughs more productive and helping clear the respiratory tract of accumulated secretions.
• Fever, headache, and body aches: Paracetamol provides effective antipyretic and analgesic action, reducing fever and relieving the pain symptoms that accompany colds and flu.
• Allergic rhinitis symptoms: Cetirizine controls sneezing, runny nose, watery eyes, and nasal itching triggered by histamine release during respiratory infections.

Why Manufacturers Choose This Combination

This five-ingredient cold and flu combination is among the highest-volume fixed-dose combinations manufactured in India. Its broad symptom coverage makes it a preferred choice for patients seeking single-tablet relief, driving strong over-the-counter demand. For manufacturers, the combination offers several advantages: well-characterised active ingredients with established supply chains, high repeat purchase rates during cold and flu seasons, and suitability for both domestic PCD franchise distribution and exports.

The tablet formulation is well-established in Indian contract manufacturing, and the combination is regularly listed in tender supplies for institutional buyers. Its popularity across all regions of India and in export markets makes it a reliable volume builder for third-party manufacturing facilities.

This makes Cetirizine + Phenylephrine + Guaiphenesin + Paracetamol + Dextromethorphan one of the most sought-after combinations for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.